| NMI promotes hepatocellular carcinoma progression via BDKRB2 and MAPK/ERK pathway | |
| He, Fu-Chu; Qin, Lun-Xiu; Zhao, Jing; Dong, Qiong-Zhu; Zhong, Fan; Cai, Li-Li; Qin, Zhao-Yu; Liu, Yang; Lin, Cheng-Zhao | |
| 刊名 | ONCOTARGET
 |
| 2017 | |
| 卷号 | 8期号:7 |
| ISSN号 | 1949-2553 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3623017 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | He, Fu-Chu,Qin, Lun-Xiu,Zhao, Jing,et al. NMI promotes hepatocellular carcinoma progression via BDKRB2 and MAPK/ERK pathway[J]. ONCOTARGET,2017,8(7). |
| APA | He, Fu-Chu.,Qin, Lun-Xiu.,Zhao, Jing.,Dong, Qiong-Zhu.,Zhong, Fan.,...&Lin, Cheng-Zhao.(2017).NMI promotes hepatocellular carcinoma progression via BDKRB2 and MAPK/ERK pathway.ONCOTARGET,8(7). |
| MLA | He, Fu-Chu,et al."NMI promotes hepatocellular carcinoma progression via BDKRB2 and MAPK/ERK pathway".ONCOTARGET 8.7(2017). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论